Altered vascular expression of EphrinB2 and EphB4 in a model of oxygen-induced retinopathy

Developmental Dynamics

Volumn 239, Issue 6, 2010, Pages 1695-1707

  Davies, Michael H ^a,b   Stempel, Andrew J ^a,b   Hubert, Kristin E ^a   Powers, Michael R ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Angiogenesis; Arteriovenous malformation; Ephb4; Ephrinb2; Neovascularization

Indexed keywords

CASPASE 3; EPHRIN; EPHRIN B2; EPHRIN B4; OXYGEN; UNCLASSIFIED DRUG; EPHRIN RECEPTOR B4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOVENOUS MALFORMATION; ARTERY; ARTICLE; CAPILLARY; CONTROLLED STUDY; FEMALE; HYPEROXIA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA BLOOD VESSEL; RETINOPATHY; VEIN; ANIMAL; BLOOD VESSEL; C57BL MOUSE; ENDOTHELIUM CELL; METABOLISM; RETINA NEOVASCULARIZATION;

ANIMALS; ARTERIES; BLOOD VESSELS; CASPASE 3; ENDOTHELIAL CELLS; EPHRIN-B2; HYPEROXIA; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; OXYGEN; RECEPTOR, EPHB4; RETINAL NEOVASCULARIZATION; VEINS;

EID: 77952697829     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.22306     Document Type: Article

References (72)

1. Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, Deutsch U, Risau W, Klein R. 1999. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 13:295-306. (Pubitemid 29095801)
2. Aitsebaomo J, Portbury AL, Schisler JC, Patterson C. 2008. Brothers and sisters: molecular insights into arterial-venous heterogeneity. Circ Res 103:929-939.
3. Benjamin LE, Hemo I, Keshet E. 1998. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125:1591-1598. (Pubitemid 28256727)
4. Bundesen LQ, Scheel TA, Bregman BS, Kromer LF. 2003. Ephrin-B2 and EphB2 regulation of astrocyte-meningeal fibroblast interactions in response to spinal cord lesions in adult rats. J Neurosci 23:7789-7800.
5. Carlson TR, Yan Y, Wu X, Lam MT, Tang GL, Beverly LJ, Messina LM, Capobianco AJ, Werb Z, Wang R. 2005. Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice. Proc Natl Acad Sci USA 102:9884-9889. (Pubitemid 40993662)
6. Chen J, Hicks D, Brantley-Sieders D, Cheng N, McCollum GW, Qi-Werdich X, Penn J. 2006. Inhibition of retinal neovascularization by soluble EphA2 receptor. Exp Eye Res 82:664-673. (Pubitemid 43122097)
7. Chen J, Connor KM, Aderman CM, Smith LE. 2008. Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest 118:526-533. (Pubitemid 351206543)
8. Cheng N, Brantley DM, Liu H, Lin Q, Enriquez M, Gale N, Yancopoulos G, Cerretti DP, Daniel TO, Chen J. 2002. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis. Mol Cancer Res 1:2-11. (Pubitemid 36330206)
9. Childs EW, Tharakan B, Byrge N, Tinsley JH, Hunter FA, Smythe WR. 2008. Angiopoietin-1 inhibits intrinsic apoptotic signaling and vascular hyperpermeability following hemorrhagic shock. Am J Physiol Heart Circ Physiol 294: H2285-2295.
10. Claxton S, Fruttiger M. 2005. Oxygen modifies artery differentiation and network morphogenesis in the retinal vasculature. Dev Dyn 233:822-828. (Pubitemid 40853458)
11. Cowan CA, Yokoyama N, Saxena A, Chumley MJ, Silvany RE, Baker LA, Srivastava D, Henkemeyer M. 2004. Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development. Dev Biol 271:263-271. (Pubitemid 38833660)
12. Davies MH, Eubanks JP, Powers MR. 2003. Increased retinal neovascularization in Fas ligand-deficient mice. Invest Ophthalmol Vis Sci 44:3202-3210.
13. Davies MH, Eubanks JP, Powers MR. 2006. Microglia and macrophages are increased in response to ischemia-induced retinopathy in the mouse retina. Mol Vis 12:467-477.
14. Davy A, Soriano P. 2005. Ephrin signaling in vivo: look both ways. Dev Dyn 232: 1-10. (Pubitemid 40070853)
15. Diehl S, Bruno R, Wilkinson GA, Loose DA, Wilting J, Schweigerer L, Klein R. 2005. Altered expression patterns of EphrinB2 and EphB2 in human umbilical vessels and congenital venous malformations. Pediatr Res 57:537-544. (Pubitemid 40389342)
16. Dimaio TA, Wang S, Huang Q, Scheef EA, Sorenson CM, Sheibani N. 2008. Attenuation of retinal vascular development and neovascularization in PECAM-1-deficient mice. Dev Biol 315:72-88.
17. Dorrell MI, Friedlander M. 2006. Mechanisms of endothelial cell guidance and vascular patterning in the developing mouse retina. Prog Retin Eye Res 25: 277-295. (Pubitemid 43782817)
18. Dorrell MI, Aguilar E, Friedlander M. 2002. Retinal vascular development is mediated by endothelial filopodia, a pre-existing astrocytic template and specific R-cadherin adhesion. Invest Ophthalmol Vis Sci 43:3500-3510. (Pubitemid 35334359)
19. Ehlken C, Martin G, Lange C, Gogaki EG, Fiedler U, Schaffner F, Hansen LL, Augustin HG, Agostini HT. 2009. Therapeutic interference with EphrinB2 signalling inhibits oxygeninduced angioproliferative retinopathy. Acta Ophthalmol [DOI: 10.1111/j.1755-3768.2009.01609.x].
20. Erber R, Eichelsbacher U, Powajbo V, Korn T, Djonov V, Lin J, Hammes HP, Grobholz R, Ullrich A, Vajkoczy P. 2006. EphB4 controls blood vascular morphogenesis during postnatal angiogenesis. Embo J 25:628-641. (Pubitemid 43237669)
21. Foo SS, Turner CJ, Adams S, Compagni A, Aubyn D, Kogata N, Lindblom P, Shani M, Zicha D, Adams RH. 2006. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 124:161-173. (Pubitemid 43069317)
22. Foubert P, Silvestre JS, Souttou B, Barateau V, Martin C, Ebrahimian TG, Lere-Dean C, Contreres JO, Sulpice E, Levy BI, Plouet J, Tobelem G, Le Ricousse- Roussanne S. 2007. PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells. J Clin Invest 117: 1527-1537. (Pubitemid 46871337)
23. Fruttiger M. 2002. Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis. Invest Ophthalmol Vis Sci 43:522-527. (Pubitemid 34113238)
24. Fruttiger M. 2007. Development of the retinal vasculature. Angiogenesis 10: 77-88.
25. Fuller T, Korff T, Kilian A, Dandekar G, Augustin HG. 2003. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells. J Cell Sci 116: 2461-2470. (Pubitemid 36790128)
26. Gaengel K, Genove G, Armulik A, Betsholtz C. 2009. Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol 29:630-638.
27. Gale NW, Baluk P, Pan L, Kwan M, Holash J, DeChiara TM, McDonald DM, Yancopoulos GD. 2001. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol 230:151-160. (Pubitemid 32171414)
28. Gerety SS, Wang HU, Chen ZF, Anderson DJ. 1999. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol Cell 4:403-414.
29. Grant MB, May WS, Caballero S, Brown GA, Guthrie SM, Mames RN, Byrne BJ, Vaught T, Spoerri PE, Peck AB, Scott EW. 2002. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 8:607-612. (Pubitemid 34633439)
30. Gridley T. 2007. Notch signaling in vascular development and physiology. Development 134:2709-2718. (Pubitemid 47305050)
31. He S, Ding Y, Zhou J, Krasnoperov V, Zozulya S, Kumar SR, Ryan SJ, Gill PS, Hinton DR. 2005. Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization. Invest Ophthalmol Vis Sci 46:4772-4779. (Pubitemid 44264583)
32. Hoffmann J, Feng Y, vom Hagen F, Hillenbrand A, Lin J, Erber R, Vajkoczy P, Gourzoulidou E, Waldmann H, Giannis A, Wolburg H, Shani M, Jaeger V, Weich HA, Preissner KT, Hoffmann S, Deutsch U, Hammes HP. 2005. Endothelial survival factors and spatial completion, but not pericyte coverage of retinal capillaries determine vessel plasticity. Faseb J 19:2035-2036.
33. Hong CC, Peterson QP, Hong JY, Peterson RT. 2006. Artery/vein specification is governed by opposing phosphatidylinositol- 3 kinase and MAP kinase/ERK signaling. Curr Biol 16:1366-1372.
34. Kertesz N, Wu J, Chen TH, Sucov HM, Wu H. 2004. The role of erythropoietin in regulating angiogenesis. Dev Biol 276:101-110.
35. Kiyono M, Shibuya M. 2006. Inhibitory Smad transcription factors protect arterial endothelial cells from apoptosis induced by BMP4. Oncogene 25: 7131-7137. (Pubitemid 44764182)
36. Korff T, Dandekar G, Pfaff D, Fuller T, Goettsch W, Morawietz H, Schaffner F, Augustin HG. 2006. Endothelial ephrinB2 is controlled by microenvironmental determinants and associates context-dependently with CD31. Arterioscler Thromb Vasc Biol 26:468-474.
37. Kudo FA, Muto A, Maloney SP, Pimiento JM, Bergaya S, Fitzgerald TN, Westvik TS, Frattini JC, Breuer CK, Cha CH, Nishibe T, Tellides G, Sessa WC, Dardik A. 2007. Venous identity is lost but arterial identity is not gained during vein graft adaptation. Arterioscler Thromb Vasc Biol 27:1562-1571. (Pubitemid 46986111)
38. Kuijper S, Turner CJ, Adams RH. 2007. Regulation of angiogenesis by Eph-ephrin interactions. Trends Cardiovasc Med 17:145-151.
39. Lackmann M, Boyd AW. 2008. Eph, a protein family coming of age: more confusion, insight, or complexity? Sci Signal 1:re2.
40. le Noble F, Moyon D, Pardanaud L, Yuan L, Djonov V, Matthijsen R, Breant C, Fleury V, Eichmann A. 2004. Flow regulates arterial-venous differentiation in the chick embryo yolk sac. Development 131:361-375. (Pubitemid 38181375)
41. Lin FJ, Tsai MJ, Tsai SY. 2007. Artery and vein formation: a tug of war between different forces. EMBO Rep 8:920-924.
42. Lobov IB, Renard RA, Papadopoulos N, Gale NW, Thurston G, Yancopoulos GD, Wiegand SJ. 2007. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci USA 104:3219-3224. (Pubitemid 46364140)
43. Marston DJ, Dickinson S, Nobes CD. 2003. Rac-dependent trans-endocytosis of ephrinBs regulates Eph-ephrin contact repulsion. Nat Cell Biol 5:879-888. (Pubitemid 37220693)
44. Muller-Ehmsen J, Schmidt A, Krausgrill B, Schwinger RH, Bloch W. 2006. Role of erythropoietin for angiogenesis and vasculogenesis: from embryonic development through adulthood. Am J Physiol Heart Circ Physiol 290:H331-340.
45. Obi S, Yamamoto K, Shimizu N, Kumagaya S, Masumura T, Sokabe T, Asahara T, Ando J. 2009. Fluid shear stress induces arterial differentiation of endothelial progenitor cells. J Appl Physiol 106:203-211.
46. Oike Y, Ito Y, Hamada K, Zhang XQ, Miyata K, Arai F, Inada T, Araki K, Nakagata N, Takeya M, Kisanuki YY, Yanagisawa M, Gale NW, Suda T. 2002. Regulation of vasculogenesis and angiogenesis by EphB/ephrin-B2 signaling between endothelial cells and surrounding mesenchymal cells. Blood 100:1326-1333. (Pubitemid 34864288)
47. Othman-Hassan K, Patel K, Papoutsi M, Rodriguez-Niedenfuhr M, Christ B, Wilting J. 2001. Arterial identity of endothelial cells is controlled by local cues. Dev Biol 237:398-409. (Pubitemid 32881130)
48. Pasquale EB. 2008. Eph-ephrin bidirectional signaling in physiology and disease. Cell 133:38-52.
49. Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE. 1995. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 92:905-909.
50. Rocha SF, Adams RH. 2009. Molecular differentiation and specialization of vascular beds. Angiogenesis
51. Saint-Geniez M, D'Amore PA. 2004. Development and pathology of the hyaloid, choroidal and retinal vasculature. Int J Dev Biol 48:1045-1058. (Pubitemid 40039191)
52. Saint-Geniez M, Argence CB, Knibiehler B, Audigier Y. 2003. The msr/apj gene encoding the apelin receptor is an early and specific marker of the venous phenotype in the retinal vasculature. Gene Expr Patterns 3:467-472. (Pubitemid 36950423)
53. Salvucci O, Maric D, Economopoulou M, Sakakibara S, Merlin S, Follenzi A, Tosato G. 2009. EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures. Blood 114:1707-1716.
54. Schmidt JF, Agapova OA, Yang P, Kaufman PL, Hernandez MR. 2007. Expression of ephrinB1 and its receptor in glaucomatous optic neuropathy. Br J Ophthalmol 91:1219-1224. (Pubitemid 47344903)
55. Shih SC, Ju M, Liu N, Mo JR, Ney JJ, Smith LE. 2003. Transforming growth factor beta1 induction of vascular endothelial growth factor receptor 1: mechanism of pericyte-induced vascular survival in vivo. Proc Natl Acad Sci USA 100:15859-15864. (Pubitemid 38021080)
56. Shin D, Garcia-Cardena G, Hayashi S, Gerety S, Asahara T, Stavrakis G, Isner J, Folkman J, Gimbrone MA Jr, Anderson DJ. 2001. Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Dev Biol 230:139-150. (Pubitemid 32171413)
57. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA. 1994. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101-111.
58. Sorensen LK, Brooke BS, Li DY, Urness LD. 2003. Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor. Dev Biol 261:235-250.
59. Stalmans I, Ng YS, Rohan R, Fruttiger M, Bouche A, Yuce A, Fujisawa H, Hermans B, Shani M, Jansen S, Hicklin D, Anderson DJ, Gardiner T, Hammes HP, Moons L, Dewerchin M, Collen D, Carmeliet P, D'Amore PA. 2002. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest 109:327-336. (Pubitemid 34141806)
60. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180. (Pubitemid 27010101)
61. Taylor AC, Murfee WL, Peirce SM. 2007. EphB4 expression along adult rat microvascular networks: EphB4 is more than a venous specific marker. Microcirculation 14:253-267.
62. Trindade A, Kumar SR, Scehnet JS, Lopes-da-Costa L, Becker J, Jiang W, Liu R, Gill PS, Duarte A. 2008. Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos. Blood 112:1720-1729.
63. Uemura A, Ogawa M, Hirashima M, Fujiwara T, Koyama S, Takagi H, Honda Y, Wiegand SJ, Yancopoulos GD, Nishikawa S. 2002. Recombinant angiopoietin- 1 restores higher-order architecture of growing blood vessels in mice in the absence of mural cells. J Clin Invest 110:1619-1628. (Pubitemid 35424240)
64. Uemura A, Kusuhara S, Katsuta H, Nishikawa S. 2006. Angiogenesis in the mouse retina: a model system for experimental manipulation. Exp Cell Res 312:676-683. (Pubitemid 43290344)
65. Umeda N, Ozaki H, Hayashi H, Oshima K. 2004. Expression of ephrinB2 and its receptors on fibroproliferative membranes in ocular angiogenic diseases. Am J Ophthalmol 138:270-279. (Pubitemid 39037432)
66. Urness LD, Sorensen LK, Li DY. 2000. Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet 26:328-331.
67. Visconti RP, Richardson CD, Sato TN. 2002. Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc Natl Acad Sci USA 99:8219-8224.
68. Wang HU, Chen ZF, Anderson DJ. 1998. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93:741-753.
69. You LR, Lin FJ, Lee CT, DeMayo FJ, Tsai MJ, Tsai SY. 2005. Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. Nature 435:98-104.
70. Yuan K, Jin YT, Lin MT. 2000. Expression of Tie-2, angiopoietin-1, angiopoietin-2, ephrinB2 and EphB4 in pyogenic granuloma of human gingiva implicates their roles in inflammatory angiogenesis. J Periodontal Res 35:165-171.
71. Zamora DO, Davies MH, Planck SR, Rosenbaum JT, Powers MR. 2005. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy. Invest Ophthalmol Vis Sci 46:2175-2182.
72. Zimmer M, Palmer A, Kohler J, Klein R. 2003. EphB-ephrinB bi-directional endocytosis terminates adhesion allowing contact mediated repulsion. Nat Cell Biol 5:869-878. (Pubitemid 37220692)